Conformal external beam treatment of prostate cancer

Urology

Volumn 50, Issue 1, 1997, Pages 87-92

  Hanks, Gerald E ^a   Hanlon, Alexandra L ^a   Schultheiss, Timothy E ^a   Freedman, Gary M ^a   Hunt, Margie ^a,b   Pinover, Wayne H ^a   Movsas, Benjamin ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION BEAM; TREATMENT OUTCOME;

HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TREATMENT FAILURE;

EID: 0030797321     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00226-4     Document Type: Article

References (14)

1. American Joint Committee on Cancer: Manual for Staging of Cancer, 4th ed. Philadelphia, JB Lippincott, 1992, pp 181-183.
2. Hermanek P, Hutter RV, and Sobin LH: Prognostic grouping. The next step in tumor classification. J Cancer Res Clin Oncol 116: 513-516, 1990.
3. Burke HB, and Henson DE: The American Joint Committee on Cancer criteria for prognostic factors and for an enhanced prognostic system. Cancer 72: 3131-3135, 1993.
4. Zagars GK, and Pollack A: Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology 45: 476-483, 1995.
5. Pisansky TM, Kahn MJ, Rasp GM, Cha SS, Haddock MG, and Bostwick DG: A multiple prognostic index predictive of disease outcome following irradiation for clinically localized prostatic carcinoma. Cancer 79: 337-344, 1997.
6. Partin AW, Pound CR, Clemens JQ, Epstein JI, and Walsh PC: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713-725, 1993.
7. Catalona WJ, and Smith DS: 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837-1842, 1994.
8. Trapasso JG, deKernion JB, Smith RB, and Dorey F: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 152: 1821-1825, 1994.
9. Murphy GP, Mettlin C, Menck H, Winchester DP, and Davidson AM: National patterns of prostate cancer treatment by radical prostatectomy - results of a survey by the American College of Surgeons Commission on Cancer. J Urol 152: 1817-1819, 1994.
10. Kupelian P, Katcher J, Levin H, Zippe C, and Klein E: Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 48: 249-260, 1996.
11. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick Ml, Smalley SR, et al: Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154: 2144-2148, 1995.
12. Hanks GE, Hanlon A, Schultheiss T, Corn B, Shipley WU, and Lee WR: Early prostate cancer - the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. J Urol 152: 1775-1780, 1994.
13. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, Martin SK, and Oesterling JE: Radical prostatectomy for clinically localized prostate cancer - long-term results of 1,143 patients from a single institution. J Clin Oncol 12: 2254-2263, 1994.
14. Krongrad A, Lai H, Lamm S, and Lai SH: Mortality in prostate cancer. J Urol 156: 1084-1091, 1996.